ReviewWorld journal of gastroenterology2015

Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2.

Satoshi Tanida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.